ATE420210T1 - Diagnose des brustkrebsrisikos - Google Patents

Diagnose des brustkrebsrisikos

Info

Publication number
ATE420210T1
ATE420210T1 AT04768320T AT04768320T ATE420210T1 AT E420210 T1 ATE420210 T1 AT E420210T1 AT 04768320 T AT04768320 T AT 04768320T AT 04768320 T AT04768320 T AT 04768320T AT E420210 T1 ATE420210 T1 AT E420210T1
Authority
AT
Austria
Prior art keywords
breast cancer
diagnosis
cancer risk
risk
cancer
Prior art date
Application number
AT04768320T
Other languages
English (en)
Inventor
Martin Andrew Crockard
Janice Roberta Bailie
John Victor Lamont
Stephen Peter Fitzgerald
Original Assignee
Randox Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Lab Ltd filed Critical Randox Lab Ltd
Application granted granted Critical
Publication of ATE420210T1 publication Critical patent/ATE420210T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04768320T 2003-09-03 2004-09-02 Diagnose des brustkrebsrisikos ATE420210T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0320648.9A GB0320648D0 (en) 2003-09-03 2003-09-03 Molecular marker

Publications (1)

Publication Number Publication Date
ATE420210T1 true ATE420210T1 (de) 2009-01-15

Family

ID=28686847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768320T ATE420210T1 (de) 2003-09-03 2004-09-02 Diagnose des brustkrebsrisikos

Country Status (9)

Country Link
US (1) US20090311671A1 (de)
EP (1) EP1660676B1 (de)
JP (1) JP2007503826A (de)
CN (1) CN1846001A (de)
AT (1) ATE420210T1 (de)
DE (1) DE602004018940D1 (de)
ES (1) ES2319533T3 (de)
GB (1) GB0320648D0 (de)
WO (1) WO2005024060A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606954D0 (en) * 2006-04-06 2006-05-17 Randox Lab Ltd Method
KR102071491B1 (ko) * 2017-11-10 2020-01-30 주식회사 디시젠 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030044859A1 (en) * 1996-08-19 2003-03-06 Henslee Jerry G. Reagents and methods useful for detecting diseases of the breast
US6012053A (en) * 1997-06-23 2000-01-04 Lycos, Inc. Computer system with user-controlled relevance ranking of search results
EP1105528A4 (de) * 1998-08-04 2002-09-04 Diadexus Inc Verfahren zur diagnose, überwachung, klassifizierung, bildgebungund behandlung von brustkrebs
US7065494B1 (en) * 1999-06-25 2006-06-20 Nicholas D. Evans Electronic customer service and rating system and method
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
CA2390802A1 (en) * 1999-11-23 2001-05-31 Diadexus, Inc. A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
JP2004511212A (ja) * 2000-05-26 2004-04-15 コリクサ　コーポレイション 卵巣癌の治療および診断のための組成物および方法
GB0026353D0 (en) * 2000-10-27 2000-12-13 Canon Kk Apparatus and a method for facilitating searching
JP2005512510A (ja) * 2001-05-16 2005-05-12 ノバルティス アクチエンゲゼルシャフト 予後および治療標的として乳癌で発現される遺伝子
DK1410011T3 (da) * 2001-06-18 2011-07-18 Netherlands Cancer Inst Diagnose og prognose for brystcancerpatienter
WO2003061386A1 (en) * 2002-01-03 2003-07-31 Board Of Regents, The University Of Texas System Wt1 antisense oligos for the inhibition of breast cancer

Also Published As

Publication number Publication date
JP2007503826A (ja) 2007-03-01
WO2005024060A1 (en) 2005-03-17
EP1660676B1 (de) 2009-01-07
DE602004018940D1 (de) 2009-02-26
GB0320648D0 (en) 2003-10-01
ES2319533T3 (es) 2009-05-08
US20090311671A1 (en) 2009-12-17
EP1660676A1 (de) 2006-05-31
CN1846001A (zh) 2006-10-11

Similar Documents

Publication Publication Date Title
ATE461294T1 (de) Brustkrebsdiagnoseverfahren
AU2003263834A1 (en) Mutations in nod2 are associated with fibrostenosing disease in patients with crohn's disease
ATE283289T1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
ATE523788T1 (de) ASSAY ZUR DIAGNOSE VON ALZHEIMER BASIEREND AUF DER BESTIMMUNG DES VERHÄLTNISSES VON SEKRETASE-Aß-SPALTPRODUKTEN
DE60324925D1 (de) Ace2-aktivierung zur behandlung von herz, lungen, und nierenkrankheit und bluthochdruck
DE60028544D1 (de) Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs
HUP0105379A2 (hu) Lawsonia intracellularis elleni oltóanyag
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
Ali et al. Molecular characterization of echinococcus species in Khyber pakhtunkhwa, pakistan
AU2003293141A8 (en) Methods for identifying risk of breast cancer and treatments thereof
EP1951891A4 (de) Krebsantigen mage-a9 und verwendungen davon
DE502006003717D1 (de) Bestimmung von kurzkettiger srl-alkoholdehydrogenase (dhrs4) als biomarker für entzündungen und infektionen
CN101045944B (zh) 检测六种腹泻致病菌的基因芯片、制备方法及试剂盒
EP1556493A4 (de) Neue vollständige genomische dna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
ATE420210T1 (de) Diagnose des brustkrebsrisikos
NO20070780L (no) Celloverflateprotein.
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
MY147511A (en) Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage-a3-marker
ATE498020T1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
WO2003104812A3 (en) DIAGNOSIS ASSAY FOR ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE HA DOLLAR G (B) 42 RATE: HA DOLLAR G (B) 40
BRPI0413364A (pt) proteases especìficas de ubiquitina
ATE335806T1 (de) Diagnosisverfahren für whipples krankheit
GB0227274D0 (en) Probes
DE602004029477D1 (de) Methode zur detektion und beobachtung von krankheiten durch analyse von an den zellen gebundenen nukleinsäuren
DE60035857D1 (de) Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties